Captor Therapeutics S.A. Cash Flow Reinvestment Rate
Captor Therapeutics S.A. cash flow reinvestment rate. Captor Therapeutics S.A. (CTX) has a Cash Flow Reinvestment Rate of 1.94x as of March 2025, reinvesting zł44.69 Million (capex zł83.00K plus investments zł-44.60 Million) from operating cash flow of zł23.06 Million. Explore Captor Therapeutics S.A. (CTX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Captor Therapeutics S.A. (2017–2019)
Cash flow reinvestment rate of Captor Therapeutics S.A. from 2017 to 2019. Historical reinvestment intensity for Captor Therapeutics S.A. across 2 annual periods. Explore Captor Therapeutics S.A. (CTX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Captor Therapeutics S.A. Cash Flow Reinvestment Rate by Year (2017–2019)
Captor Therapeutics S.A. cash flow reinvestment rate by year from 2017 to 2019. Year-by-year capital reinvestment analysis for Captor Therapeutics S.A.. For the full cash flow conversion analysis, see CTX operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.10x | zł460.00K | zł4.39 Million | zł229.00K | — |
| 2017 | 0.00x | zł0.00 | zł2.10 Million | zł0.00 | — |